Abstract. Previous 
ilarity of the GH binding protein to the liver membrane GH receptor. Since GH regulates its own liver receptors, we examined the effects of short-and long-term hGH therapy on GH binding protein in children with GH deficiency. Six GH-deficient children received their first hGH dose ever, and the pharmacodynamics of serum GH was followed for 12 h, along with measurements of GH binding protein activity. Over the first 6 h, serum GH and GH binding protein activity exhibited a parallel increase, followed by gradual decrease. At 8 h, some of the patients exhibited an apparent second peak in GH binding protein, despite the continuous decrease in serum hGH. During the period of hGH treatment, serum GH binding protein increased progressively over a period of 6 months. In a second uncontrolled group of 7 GH-deficient patients who had been treated with hGH for 30-36 months, GH binding protein activity was also significantly higher than pretreatment values. We suggest that the short-term pharmacodynamic changes probably represent the endogenous turnover of the GH receptor, whereas the elevated GH binding protein activity on hGH treatment may reflect up-regulation of the GH receptor.
The notion that the serum GH-binding protein (GHBP) might arise from the liver and be struc¬ turally related to the hepatic membrane GH recep¬ tor was entertained from the early report on rabbit 1 (6) and binding characteristics in terms of specific¬ ity and affinity (7, 8) . It has also been shown that IM-9 lymphocytes, a cell line which proliferates upon stimulation by somatogenic GH, can release GHBP to the culture medium (9) . These (10) (11) (12) . We have recently shown that the pulsatile secretion of GH is associated with concurrent fluctuations in GH receptors in rat liver plasma membranes (13, 14) and in GHBP (15, 16 (Fig. 1, panel C) . The significance of GHBP natural fluctuation was p<0.001.
GH therapy
In the first group of GH-deficient patients, the pretreatment GHBP activity was comparable to that of short-statured children with normal GH secretion: 6.5±0.4 vs 7.4±0.2% of radioactivity, respectively, but significantly lower than that for adult subjects (11.32±0.45%, p<0.001). During the period of GH therapy, the GHBP activity increased progres¬ sively to 8.5±0.7% (p<0.05) and 9.5±0.9% of ra¬ dioactivity (p<0.02) (Fig. 2) 
Discussion
In the present study we documented the short and long-term effects of GH on GHBP levels in GHdeficient patients. We found that in the short term GHBP follows the pattern of GH pharmacodynamics, whereas in the long term GH therapy upregulated GHBP levels.
The assay of GHBP used here was previously characterized and validated against other assays (17). The 
